Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > 99% Injection Tirzepatide High Quality Weight Loss Fast Shipping
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - large image1
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image1
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image2
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image3
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image4
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image5
99% Injection Tirzepatide High Quality Weight Loss Fast Shipping buy - image6

99% Injection Tirzepatide High Quality Weight Loss Fast Shipping

TDS 2115 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99.5%

Port:

Hangzhou

Brand:

HyperChem

Packaging:

1g/bottle, 1kg/Tin, 1kg/Bag

Price valid (until):

2024-10-24

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Name

    Tirzepatide

    CAS number

    2023788-19-2

    Synonym

    BG 121; BG-121; BG121; LY 3298176; LY3298176; LY-3298176; Tirzepatide

    Related CAS

    NA

    Description

    Tirzepatide is a newly developed glucose-lowering agent which acts on the glucose-dependent

    otropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been shown to result in several highly beneficial outcomes including weight loss and a significant improvement in important metabolic parameters such as HbA1c, fasting serum glucose, and triglyceride/lipoprotein levels. These findings suggest that tirzepatide could potentially be beneficial to metabolically healthy obese or metabolically healthy overweight patients in reducing their risk of adverse cardiovascular outcomes and conversion to the metabolically unhealthy phenotype.

    Structure

    Shop 99% Injection Tirzepatide High Quality Weight Loss Fast Shipping-Detailed Image 1

    Molecular Formula

    C225H348N48O68

    Molecular Weight

    4810.52 g/mol

    Appearance

    White solid powder

    Quality Standard

    USP EP

    Shipping Condition

    Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

    Storage Condition

    Dry, dark and at 2~8 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

    Shelf Life

    >2 years if stored properly

    Sample package

    Aluminium foil bag, Bottle

    Commercial package

    Aluminium Tin

    Origin

    China


    Tirzepatide More Info

     

    Tirzepatide is a novel medication used for the treatment of type 2 diabetes and weight loss. It is a dual agonist that activates both the glucose-dependent 

    polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor.

    Mechanism of Action

    • Tirzepatide stimulates release from the pancreas and reduces hyperglycemia by activating GLP-1 receptors.
    • It increases sensitivity and secretion by activating GIP receptors, helping to regulate blood glucose levels.
    • Tirzepatide also delays gastric emptying and increases satiety, leading to reduced food intake and weight loss.

    Pharmacokinetics

    • Tirzepatide has an 80% bioavailability following subcutaneous administration.
    • Peak serum levels are reached within 8 to 72 hours.
    • It has a half-life of approximately 5 days, allowing for once-weekly dosing.
    • Tirzepatide is primarily eliminated through urine and feces as metabolites.

    Clinical Uses

    • Tirzepatide is approved for the treatment of type 2 diabetes in adults as an adjunct to diet and exercise.
    • It can be used as a single therapy or in combination with other diabetes medications, such as metformin, sulfonylureas, or SGLT2 inhibitors.
    • Tirzepatide is also approved for weight loss in adults with obesity or overweight individuals with weight-related medical problems.

    Side Effects

    The most common side effects of tirzepatide include:

    • Gastrointestinal symptoms: nausea, vomiting, diarrhea, constipation, abdominal pain
    • Decreased appetite
    • Injection site reactions

    Serious side effects, though less common, may include:

    • Severe allergic reactions
    • Thyroid tumors
    • Pancreatitis
    • Hypoglycemia (when used with sulfonylureas)
    • Acute kidney injury

    Patients should be monitored for signs of these adverse effects and seek immediate medical attention if they occur.

     

    In summary, tirzepatide is a promising dual GIP and GLP-1 receptor agonist that offers a new approach to managing type 2 diabetes and promoting weight loss. While generally well-tolerated, patients should be aware of potential side effects and report any concerning symptoms to their healthcare provider.

     


    Product Image

    Shop High Quality Oxytocin CAS 50-56-6-Detailed Image 2

    Shop USP Quality Standard API Finasteride Powder with CAS 98319-26-7-Detailed Image 3



    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

    Location:

    Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    10 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2013

    Company Certificates
    • Hangzhou Hyper Chemicals LimitedCertification Report by Bureau Veritas Certification Report by Bureau Veritas
    About HyperChem

    Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

    Our Competitiveness

    One-stop supply

    Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

    Among all the pharmaceuticals,

    90% of them with GMP certificates,

    85% of them with DMF files and

    50% of them passed FDA approval,

    30% get CEP certificate

    20% are new R&D products.

    Custom Repackaging Service


    We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

    Quality Control/Quality Assurance


    HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

    All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

    Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

    Professional

    Transparent Communication

    Fast Reaction,

    Professional Suggestion

    Beyond Expectation.

    We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

  • Inquiry History
    2115 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Brazil

    2023788-19-2

    20 PCS Sep 12, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    2  Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    1  Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Bolivia

    peptideos

    10000 G Feb 12, 2026
    Malaysia

    Tirzepatide

    40 MG Jul 23, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.